Breast Cancer Trials

Rebecca was diagnosed at 33 years old when her son was just 11 months old. She found a lump one day but assumed it was related to mastitis from breast feeding and was shocked to find out it was cancer. Rebecca discusses what it’s like to be diagnosed as a young woman and how grateful she is for breast cancer research.

Clinical Psychologist Dr Lisa Beatty explains what online help is available & what the benefits are of using psychological breast cancer online tools.

Cancer Geneticist Associate Professor Judy Kirk explains who should get genetic testing, what exactly a ‘strong family history’ means and how you can get tested.

Gowri Sivalingam was diagnosed in 2015 with invasive ductal carcinoma after finding a lump in her breast on Christmas day. She spoke with us about being diagnosed with breast cancer as a young woman, working throughout treatment, participating in a clinical trial and what it’s like to be diagnosed with cancer when you are a doctor.

Breast Surgeon at Belfast City Hospital, Dr Stuart McIntosh, discusses clinical trials open in the UK & explains it’s hoped these trials will open in Australia & NZ.

Radiation therapy uses doses of radiation to kill cancer cells & shrink tumors. In this Breast Cancer Trials Podcast, Professor Julia White explains why it is an important part of breast cancer treatment.

Marie Pandeloglou was diagnosed with metastatic breast cancer 4 and a half years after her early breast cancer diagnosis. She shares what it is like to live with metastatic disease, what she wants people to know about metastatic breast cancer, and her advice for those living with breast cancer.

One of the best ways to diagnose breast cancer early, aid in treatment decisions or predict treatment response is to use cancer biomarkers. HER2 positive early breast cancer molecular biomarkers are a research area for Associate Professor Aleix Prat. He explains that investigating HER2 positive early breast cancer is important as it can become an aggressive disease if left untreated.

Breast Cancer Network Australia (BCNA) surveyed 2,000 of its members who have received a breast cancer diagnosis about the out-of-pocket costs of their breast cancer treatment and care, and other associated costs faced in the first five years after a breast cancer diagnosis. We sat down with BCNA's CEO Kirsten Pilatti to find out more about their findings.

Most cancer researchers spend their careers focusing on one disease type. Professor Wayne Tilley has instead specalised in two; breast and prostate cancer. He is renowned for leveraging the commonalities of both to advance knowledge and treatments for both treatment types. He sat down with us to discuss his research.

The BIG 1-98 breast cancer clinical trial was a pivotal clinical trial which helped to stop breast cancer returning and improved survival rates for some women.

It’s a common misconception that men can’t get breast cancer, however just under 1% of all breast cancers will occur in men. To help explain how breast cancer occurs and is treated in men - we sat down with Rik Thompson, Professor of Breast Cancer Research and a Breast Cancer Trials Board Member.

A liquid biopsy is a simple and non-invasive alternative to surgical biopsies, which enables doctors to discover a range of information about a tumour through a simple blood sample. We speak with Professor Rik Thompson about how liquid biopsy relates to breast cancer treatment and why it's important in metastatic breast cancer.

How kind were you to yourself during and after your breast cancer treatment? On this episode of the Breast Cancer Trials podcast we speak with two women who have experienced a breast cancer diagnosis and find out about their experiences with mental health, body image and breast cancer.

Breast Cancer Trials was the first clinical trials group to invite people with a lived experience with cancer to comment and guide the planning and conduct of clinical trials research. These women make up our Consumer Advisory Panel. Listen to former chair of the panel, Leonie Young, discuss the importance of this perspective in the clinical trials research process.

Immunotherapy allows cancer to become more visible to the immune system so it can then attack it. The PANACEA trial was Breast Cancer Trials first immunotherapy trial, and it has lead to further research into this area. Listen in to Associate Professor Prue Francis discuss the benefits of this trial, and the future of Immunotherapy in breast cancer care.

A breast cancer diagnosis can come as a huge shock to a young women and the challenges that come with their diagnosis can be different to women at a later stage in life. We speak with Breast Cancer Trials Associate Professor Prue Francis about how common it is for young women to be diagnosed with breast cancer, what challenges come with this diagnosis and how Breast Cancer Trials is working to improve the treatments for those in this age group.

The SOLACE clinical trial was for women or men who had been diagnosed with advanced BRCA-associated breast cancer, triple negative breast cancer or serious ovarian cancer. Listen in to see how these results are informing current research into ovarian and breast cancer.

Did you know women with dense breasts can be five times more likely to develop breast cancer. In this podcast episode, we talk with breast cancer researcher Professor Rik Thompson about mammographic density - who has it, what causes it, and why aren't we more aware of it.

Breast cancer clinical trials have played a significant role in improvements to breast cancer survival rates and treatments over the last 30 years. Breast Cancer Trials Deputy Director of Research, Professor Kelly-Anne Phillips explains that a clinical trial is research in action.